|Articles|February 1, 2016
- Applied Clinical Trials-02-01-2016
- Volume 25
- Issue 2
Applied Clinical Trials, February/March 2016 Issue (PDF)
Click the title above to open the Applied Clinical Trials February/March 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
FDA Looks to New Techology, Policies to Streamline Clinical Researchalmost 10 years ago
EMA Adopts New Strategy on Measuring Impact of Pharmacovigilancealmost 10 years ago
Ambition vs. Assessment: The Approval-Reimbursement Dividealmost 10 years ago
How Do You View the Future of Wearables?almost 10 years ago
Competitive Pressure for First-in-Class Drugs is Intensifyingalmost 10 years ago
What Google Can Teach Us About Trial Education, Awarenessalmost 10 years ago
Preventing Patient Centricity from Becoming a Fadalmost 10 years ago
Clinical Trial Knowledge Missed, Gained, and Sharedalmost 10 years ago
Investigator Characteristics & Patient Recruitment in ALLHATalmost 10 years ago
Barriers to Trial Recruitment and Possible SolutionsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
3
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
4
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
